Journal of Hepatology, an international top rank journal
Authors: Didier Samuel
Journal: Journal of Hepatology (2013)

As Editors we are proud to announce that the 2012 impact factor is 9.858, the highest ever reached for the Journal of Hepatology. We certainly hope to continue on this increasing trend in the next years. In addition, this is the third year in a row with an impact factor of over 9 for the Journal, and thus it confirms the strong position of the Journal among the top rank journals in the field of hepatology. This is a strong message for our authors: they can be confident to have their papers accepted and published in a high level journal with a growing international visibility. We know that to achieve this we had to be highly selective to choose the best 240 among the 2000 original manuscripts submitted each year. This is always painful for authors whose manuscripts have been rejected, but extremely encouraging and valorising for those with an accepted manuscript. We therefore encourage authors to submit their best basic science and clinical papers first to the Journal. This will certainly be a win-win strategy. At this end, we furthermore improve the quality and presentation of the accepted manuscripts, by redrawing tables and figures in close, interactive collaboration with the authors. Accepted manuscripts are accessible online within one week after acceptance, and are fully citable, while the corrected proofs are published online within 4–6 weeks of acceptance and the printed version is available 3–4 months after acceptance. The visibility of outstanding manuscripts is increased by our web editors, who present selected manuscripts on our website, and by publishing carefully chosen video casts of accepted manuscripts on our website and our YouTube channel. In addition, we invite authors to also submit graphical abstracts, summarizing their findings in a concise, pictorial manner, which will be displayed on the website. Moreover, to reach an even wider audience, the Journal is also present in social media such as Facebook, Twitter, LinkedIn, and Google+. In our continuous effort to increase quality and visibility, we have recently launched an iPad application [[1]<https://itunes.apple.com/us/app/journal-of-hepatology/id662095076?mt=8>.Google Scholar] of the Journal reflecting almost identically the printed version. We encourage you to download the iPad app of the Journal and to give us your feedback, and we hope you will enjoy and use it. Moreover, we will probably launch an android version of this app within the next months. As said in a previous editorial, we wish to have a balanced representation of clinical and basic research in the Journal, keeping our criteria of excellence and originality in our editorial choices. We also remind our readers and authors of our strong commitment to publish high quality papers from all over the world, thus reinforcing our international representation. This new coming year is our fifth year of mandate, it has been a continuous pleasure to work for the Journal. I hope you enjoyed the evolution of the Journal over the years. I wish to thank the team of co-Editors, associate Editors and special section Editors for their outstanding input to the Journal during these last 4 years. I wish to thank the Editorial team in Geneva, Simona Negrini, Joël Walicki, Laurence Zulianello and, more recently, Esther M.N. Dohmann for their highly professional work and their close interaction with the editors. I thank Grégoire Pavillon, Executive Director of the EASL office, for his strong support over the years. I thank also the governing board of EASL, Mark Thurz and Markus Peck, the general secretaries, for their continuous support to our team. We wish you an Excellent Year 2014.